How should a patient with suspected dengue fever presenting with hematemesis and melena be managed?

Management of Hematemesis and Melena in Suspected Dengue Fever

A patient with suspected dengue fever presenting with hematemesis and melena requires immediate hospitalization with aggressive fluid resuscitation using crystalloids (20 mL/kg bolus), close hemodynamic monitoring, blood product transfusion when hemoglobin falls below 100 g/L, and consideration of urgent endoscopic intervention if bleeding persists despite supportive measures.

Immediate Resuscitation and Stabilization

This presentation represents severe dengue with gastrointestinal bleeding, which carries significant mortality risk and demands urgent intervention. The priority is restoring tissue perfusion and preventing shock 1.

Fluid Resuscitation Strategy

• Administer crystalloid bolus of 20 mL/kg immediately upon recognition of shock or tissue hypoperfusion 2, 3
• Target adequate tissue perfusion as the primary endpoint: warm extremities, capillary refill <3 seconds, urine output >0.5 mL/kg/hour in adults, normal mental status 1
• Continue liberal fluid infusions for 24-48 hours; more than 4 liters may be required in the first 24 hours for adults 1
• Use crystalloids as first-line (normal saline or Ringer's lactate); colloids may be considered in severe dengue shock syndrome with pulse pressure <10 mmHg 1

Critical caveat: While aggressive fluid resuscitation is essential in dengue shock syndrome, monitor closely for fluid overload which can precipitate pulmonary edema 1. Reassess frequently after each bolus.

Hemodynamic Monitoring and Support

Assessment Parameters

• Insert urinary catheter and measure hourly output (target >30 mL/hour) 4
• Monitor pulse, blood pressure continuously with automated monitoring 1
• Target systolic blood pressure ≥90 mmHg in adults 1
• Assess for clinical indicators of adequate perfusion: absence of skin mottling, well-felt peripheral pulses, normal capillary refill 1

Vasopressor Support

If tissue hypoperfusion persists despite liberal fluid resuscitation:

• Use dopamine or epinephrine (adrenaline) for fluid-refractory shock 1
• Measure arterial blood pressure and heart rate frequently 1
• Consider hydrocortisone (up to 300 mg/day) or prednisolone (up to 75 mg/day) in adults requiring escalating vasopressor doses 1

Blood Product Transfusion

Transfuse red blood cells when:

• Hemoglobin <100 g/L in the setting of acute bleeding 4
• Active hematemesis with shock 4
• Hemoglobin <40 g/L, or <60 g/L with signs of heart failure 5

The evidence supports this threshold as mortality in critically ill patients relates to severity of anemia, and changes in cardiac output occur at hemoglobin levels around 100 g/L 4.

Endoscopic Intervention

Perform urgent endoscopy when:

• Bleeding persists despite adequate resuscitation 4
• Hemodynamic instability continues with ongoing blood loss 6
• Patient has been adequately resuscitated (stable blood pressure and central venous pressure when possible) 4

Recent case evidence demonstrates successful endoscopic hemostasis using clips and adrenaline injection in severe dengue with GI bleeding 6. Endoscopy should only be performed by experienced endoscopists capable of therapeutic interventions 4.

Important consideration: In severely bleeding patients, consider endotracheal intubation before endoscopy to prevent pulmonary aspiration 4.

Diagnostic Workup

Laboratory Monitoring

• Complete blood count with platelet count (expect thrombocytopenia <100,000/mm³) 7
• Hemoglobin levels serially to assess ongoing blood loss
• Coagulation profile (PT, aPTT, fibrinogen) 8
• Liver function tests (transaminases, bilirubin) 9
• Blood glucose monitoring (hypoglycemia can complicate severe dengue) 5

Dengue Confirmation

• RT-PCR for dengue virus if within 5 days of symptom onset 10
• Dengue NS1 antigen testing 10
• IgM/IgG serology if presenting after day 5 10

Critical pitfall: Do not delay treatment waiting for dengue confirmation. Manage empirically based on clinical presentation and epidemiologic risk 11.

Specific Dengue Considerations

Avoid Harmful Interventions

• Do NOT use NSAIDs or aspirin (increases bleeding risk)
• Use paracetamol for fever control 5
• Avoid intramuscular injections when possible (bleeding risk)

Monitor for Complications Beyond Bleeding

• Plasma leakage (hemoconcentration, pleural effusion, ascites) 12
• Hepatic dysfunction (elevated transaminases common) 9, 8
• Rare complications: hemophagocytic lymphohistiocytosis (persistent fever, worsening cytopenias, hyperferritinemia >40,000 ng/mL) 8

Differential Diagnosis

Do not assume thrombocytopenia alone explains bleeding. Consider:

• Underlying coagulopathy (Factor XI deficiency has been reported with dengue) 13
• Peptic ulcer disease as bleeding source 6, 13
• Intravascular hemolysis (check LDH, indirect bilirubin, reticulocyte count) 8

Disposition and Monitoring

• Hospitalize all patients with hematemesis/melena and suspected dengue 4, 11
• Place in semi-recumbent position (head elevated 30-45°) 1
• Continuous monitoring during critical phase (typically days 3-7 of illness) 11
• Reassess frequently for deterioration or development of shock 2, 3

The mortality rate for severe dengue with appropriate management is 1-5%, but can be significantly higher without prompt recognition and treatment 11. Conservative management with aggressive supportive care is effective in most cases 14, but readiness for endoscopic or surgical intervention is essential when bleeding persists.